… of Raw was obtained after 4 puffs of albuterol administered via an MDI with no further … (36)
found no dose–response relationship with albuterol administered via an MDI but a 10% …

… disease, which is when these drugs are often administered. The one documented benefit
of inhaled albuterol in CF is use before administration of an osmotic agent, such as hypertonic …

… design to compare the bronchodilation from salbutamol given … the bronchodilator effect of
terbutaline administered by UDN … to suggest that maximal bronchodilation is not achieved with …

Full article: Clinical benefit of fixed-dose dual bronchodilation with glycopyrronium and
indacaterol once daily in patients with chronic obstructive pulmonary disease: a systematic …

… the prediction of clinical benefit in a randomized controlled trial of inhaled albuterol and oral
… Administration of the bronchodilator was conducted under the supervision of the research …

… bronchodilator response has been defined by a short-term increase in FEV 1 , after bronchodilator
administration, … The absence of this degree of bronchodilator response suggests that …

… albuterol administration or 30 min following ipratropium bromide administration.9, 12 When
determining acute bronchodilator … the ATS criteria and clinical benefits based on measures …

… real clinical benefit and period of hospitalization. This is also true of clinical trials which show
the beneficiai effects of bronchodilators. The contrast between the evident effectiveness of …

… required on the benefits of long-acting bronchodilators on exercise tolerance [… benefits
of tiotropium plus salmeterol versus either monotherapy alone, while suggesting co-administration …

… who received salbutamol administration, bronchodilator response was negatively correlated
… patients with clinically stable bronchiectasis who underwent pre- and post-bronchodilator (…